What Myeloid-Derived Suppressor Cell Functional assays Deliver
Myeloid-derived suppressor cell (MDSC) functional assays are used to investigate immune suppression in the tumor microenvironment and to support target selection, mechanism-of-action studies, and lead candidate evaluation. Programs often struggle with poor representation of suppressive myeloid populations, difficulty modeling immune suppression, and limited understanding of immune cell interactions. Our immuno-oncology assay services combine human-relevant immune cell models with functional readouts so teams can assess suppressive activity in a controlled, project-scoped setting.
Assays are typically run in human-relevant co-culture systems: myeloid-derived suppressor cell populations are prepared or differentiated alongside responder immune cells such as primary T cells, with tumor cells, macrophages, or other stromal components added where the biological question requires them. Engagements follow a consistent commercial workflow — scoping and assay design, model setup and input QC, execution and readout collection, then analysis and reporting — and each project fixes its controls, replicate structure, and acceptance criteria before execution begins.
Each engagement is designed around your question, for example whether a candidate modulates MDSC-mediated suppression of T cell responses, and results are reported as quantified readouts with the analysis context agreed at project start. Functional assessment supports decision-making; it does not by itself establish clinical efficacy.
Parallel Treg suppression and T cell functional rescue assays can help distinguish myeloid-mediated suppression from regulatory T cell effects.
Assay Capabilities You Can Scope
Human-Relevant Co-Culture Models
MDSC assay formats can be built on human-relevant systems, including PBMC- or primary cell-derived myeloid populations co-cultured with responder immune cells and, where relevant, tumor or stromal components. The model format, cell sources, and assay configuration are confirmed during project scoping.
Suppression Readout Design
Readouts are selected during project design to match your hypothesis — for example, assessing suppression of responder cell activation or proliferation in the presence and absence of myeloid populations, with appropriate controls included as scoped.
Candidate Evaluation
Test articles can be incorporated to evaluate whether a candidate alters MDSC-associated suppression in the model. Comparisons are designed case by case, and interpretation is limited to the assay context agreed in the statement of work.
QC and Run assessment
Model setup and assay runs are checked against the agreed design, including confirmation of cell inputs and assay conditions, with pass/fail status recorded against the acceptance criteria defined in the statement of work.
How an MDSC Functional Assay Engagement Runs
What You Receive
| Deliverable | Description |
|---|---|
| Assay-ready study design | A written project plan covering the myeloid-derived suppressor cell (MDSC) model, suppression readout, controls, replicate structure, and acceptance criteria agreed before work begins. |
| Functional suppression dataset | Quantified readouts from MDSC-mediated suppression assays, with responder and control group comparisons presented in a structured data package. |
| Control and comparator results | Results for the relevant background and comparator arms included in the agreed design, so suppression signals can be interpreted against a defined baseline. |
| QC and run summary | A run-level summary documenting assay conditions, pass/fail status against the agreed acceptance criteria, and any deviations noted during execution. |
| Analysis-ready figures and tables | Figures and tables summarizing the quantified readouts from the agreed assay comparisons, provided together with the study report. |
Why Choose Our MDSC Functional Assay Services
Built around immune suppression, not generic immunology
Our immuno-oncology work is organized around the questions that decide programs: how immune cells, stromal cells, and cancer cells interact, and how suppression shapes the readout.
Human-relevant model selection
Model choice is discussed during scoping and matched to your question, sample type, and timeline. Where human-relevant systems are appropriate, we help you select a model that represents the suppressive compartment you need to interrogate, and we document the rationale in the study plan.
Defined acceptance criteria before execution
Data you can act on
Deliverables are packaged for decision-making, not just data transfer. You receive quantified suppression readouts, comparator results, QC status, and a short interpretation memo that separates what the assay supports from what it does not, so internal stakeholders can review the same evidence.
Further Reading
Research reference
1. Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function
OncoImmunology. 2024. DOI: 10.1080/2162402X.2023.2300882.
View articleDiscuss Your Myeloid-Derived Suppressor Cell Functional Assay
Share your target, model system, and the suppressive or effector readouts you need, and our team will outline a scoped assay plan with defined controls, timelines, and deliverables. Scope, sample numbers, and validation depth are agreed in the project SOW before work begins.
Follow-up tumor organoid–immune cell co-culture assays can investigate suppressive effects in a tumor–immune co-culture setting.